Simoa Technology Platform Expands Into New Market
Quanterix Corporation’s HD-X Simoa Immunoassay Analyzer has received Class 1 Medical Device registration in South Korea.
Read More
Search Results for: liver disease
Rapid NGS Technology Accelerates Clinical Trial Breakthroughs in Oncology
Precision oncology is undergoing rapid transformation driven by NGS technology, but systemic barriers in testing access must be overcome.
Read More
Rewriting the Hepatitis Playbook from B to C
Hepatitis B and C remain major global health threats due to persistent gaps in diagnosis, treatment access, and implementation of care.
Read More
Esophageal Precancer Testing Program Launched at Hoag
Lucid Diagnostics and Hoag have launched a comprehensive esophageal precancer screening program using the non-endoscopic EsoGuard DNA test.
Read More
Should Labs Add Lp(a) Testing to Their Menus?
Lipoprotein(a), or Lp(a), is a genetically determined and under-recognized cardiovascular disease risk factor.
Read More